The factor V Leiden mutation is not a common cause of recurrent miscarriage

被引:104
作者
DizonTownson, DS [1 ]
Kinney, S [1 ]
Branch, DW [1 ]
Ward, K [1 ]
机构
[1] UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132
关键词
factor V Leiden mutation; recurrent miscarriage; thrombosis;
D O I
10.1016/S0165-0378(97)00039-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Some investigators suggest that placental thrombosis and infarction can cause recurrent miscarriage. We have shown that the common missense mutation in the factor V gene, the Leiden mutation, which renders factor Va resistant to cleavage inactivation by activated protein C, predisposes to placental thrombosis and spontaneous miscarriage. Our objective was to determine the frequency of the Leiden mutation in a population with well-characterized idiopathic recurrent miscarriage. DNA was extracted from whole blood of 40 couples with a history of idiopathic recurrent miscarriage and 25 couples with a history of proven fertility (seven or more live births). The polymerase chain reaction was used to amplify exon 10 of the factor V gene followed by allele-specific restriction with Mnl1 for mutation detection. Results were analyzed with a chi(2) contingency table. None of the 40 women with idiopathic recurrent miscarriage carried the mutation and only one of their reproductive partners was heterozygous for the mutation. Similarly, none of the control women carried the mutation, and only one of the 25 control male partners was heterozygous for the mutation. In our referral population, the factor V Leiden mutation which predisposes to thrombosis is not a common cause of recurrent miscarriage. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 23 条
[1]   ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS [J].
ALARCONSEGOVIA, D ;
DELEZE, M ;
ORIA, CV ;
SANCHEZGUERRERO, J ;
GOMEZPACHECO, L ;
CABIEDES, J ;
FERNANDEZ, L ;
DELEON, SP .
MEDICINE, 1989, 68 (06) :353-365
[2]   IMPAIRMENT OF THE PROTEIN-C ANTICOAGULANT PATHWAY IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, ANTICARDIOLIPIN ANTIBODIES AND THROMBOSIS [J].
AMER, L ;
KISIEL, W ;
SEARLES, RP ;
WILLIAMS, RC .
THROMBOSIS RESEARCH, 1990, 57 (02) :247-258
[3]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]   INDUCTION OF ENDOTHELIAL-CELL TISSUE FACTOR ACTIVITY BY SERA FROM PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME - A POSSIBLE MECHANISM OF THROMBOSIS [J].
BRANCH, DW ;
RODGERS, GM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) :206-210
[6]  
BRANCH DW, 1992, OBSTET GYNECOL, V80, P614
[7]  
BRAULKE I, 1993, FERTIL STERIL, V59, P98
[8]  
CARIOU R, 1986, NEW ENGL J MED, V314, P119
[9]   DECIDUAL VASCULOPATHY AND EXTENSIVE PLACENTAL INFARCTION IN A PATIENT WITH REPEATED THROMBOEMBOLIC ACCIDENTS, RECURRENT FETAL LOSS, AND A LUPUS ANTICOAGULANT [J].
DEWOLF, F ;
CARRERAS, LO ;
MOERMAN, P ;
VERMYLEN, J ;
VANASSCHE, A ;
RENAER, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 142 (07) :829-834
[10]  
DIZONTOWNSON D, 1997, IN PRESS AM J OBSTET